静脈ステント市場：セグメント別規模、シェア、法規制、償還、インターベンション、2036年までの予測

静脈ステントは、自己拡張可能な金属製ステントで、静脈血管系の閉塞や閉塞によって引き起こされる血流の狭窄を防ぐために静脈に挿入される穿孔チューブを備えています。静脈ステントの留置は、著しい狭窄や外因性の圧迫がある場合に考慮されます。腸大腿静脈に留置される静脈ステントは、この市場で追跡されています。

慢性静脈疾患（CVD）または慢性静脈不全（CVI）は、発展途上国および先進国にとって世界の負担となっています。これは、下肢の静脈壁や弁が効率的に機能せず、血液が下肢から心臓に戻るのがますます困難になる状態を指します。深部静脈血栓症（DVT）は、身体の太い深部静脈に血栓が形成される、生命を脅かす可能性のある疾患です。DVTの多くは腸骨大腿静脈の近位または遠位、骨盤部に起こります。DVTは体の他の部位に起こることもあります。深部静脈血栓症（DVT）は急性/亜急性および慢性に分類されます。重大な狭窄や外因性圧迫がある場合には、静脈ステントの留置が考慮されます。

当レポートは、世界の静脈ステント市場について詳細に考察し、市場における競合情勢、SWOT分析、2036年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されている静脈ステントと競合情勢

• 主要な業界動向の洞察
• 静脈ステントのセグメント別総市場収益と2015年～2036年の市場展望
• セグメント別のインターベンション総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 静脈ステント市場のSWOT分析
• 静脈ステント市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Venous Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

A venous stent is a self-expandable metallic stent with perforated tube which is inserted into a vein to prevent the blood flow constriction caused by obstructions and occlusions in the venous vasculature. Venous stent placement is considered in case of significant stenosis or extrinsic compression. Venous stents placed in the iliofemoral vein have been tracked in this market.

Chronic Venous Disease (CVD) or Chronic venous insufficiency (CVI) has emerged as a global burden on developing and developed countries. It refers to the condition where venous walls and/or valves in the leg are not working efficiently and becomes increasingly difficult for blood to return to the heart from the legs. Deep Vein Thrombosis (DVT) is a potential life threating condition where a blood clot is formed in the large deep veins in the body. Most of the DVT occurs proximal or distal to the iliofemoral vein as well as in the pelvic area. They also can occur in other parts of the body. Deep Vein Thrombosis (DVT) can be characterized as acute/subacute and chronic. Venous stent placement is considered in case of significant stenosis or extrinsic compression.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Venous Stents market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Venous Stents market revenue by segment and market outlooks from 2015-2036.
• Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Venous Stents market.
• Competitive dynamics insights and trends provided Venous Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Becton Dickinson and Co, CR Bard Inc, Cook Medical Inc, Medtronic Plc, OptiMed Medizinische Instrumente GmbH, Plus Medica GmbH.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Venous Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Venous Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Venous Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Venous Stents market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.